Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)

Shandong Xinhua Pharmaceutical Company Revenue

Shandong Xinhua Pharmaceutical Company had revenue of 2.00B CNY in the quarter ending September 30, 2024, with 9.67% growth. This brings the company's revenue in the last twelve months to 8.34B, down -2.45% year-over-year. In the year 2023, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.10B with 7.97% growth.

• Revenue (ttm): 8.34B CNY
• Revenue Growth: -2.45%
• P/S Ratio: 0.44
• Revenue / Employee: 1.17M CNY
• Employees: 7,104
• Market Cap: 9.84B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.10B	597.86M	7.97%
Jan 1, 2023	7.50B	942.91M	14.37%
Dec 31, 2021	6.56B	554.49M	9.23%
Dec 31, 2020	6.01B	399.57M	7.13%
Dec 31, 2019	5.61B	361.38M	6.89%